Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study

Misbah Noshela Ghazanfar*, Ewa Anna Bartko, Nicolai Skovbjerg Arildsen, Lars K. Poulsen, Bettina Margrethe Jensen, Christian Enevold, Jesper Grønlund Holm, Anders Woetmann, Niels Ødum, Simon Francis Thomsen

*Corresponding author for this work
1 Citation (Scopus)
Original languageEnglish
JournalClinical and Experimental Allergy
Issue number5
Pages (from-to)715-718
Number of pages4
Publication statusPublished - May 2022


  • Anti-Allergic Agents/therapeutic use
  • Chronic Disease
  • Chronic Urticaria/drug therapy
  • Humans
  • Omalizumab/therapeutic use
  • Prospective Studies
  • Treatment Outcome
  • Urticaria/diagnosis

Cite this